DDX3Y and B-cell non-Hodgkin lymphoma: However, one observation that remained coherent between the two studies is that both models, male BL patients and male mice with immature B cell lymphoma, show respectively aberrant and high DDX3Y expression that compensates for the loss of DDX3X (47, 48) (Figures 5, 6).